Search Within

Pedram Razavi

Formats
  1. Meeting Abstract (85)
  2. Journal Article (83)
  3. Editorial (2)
  4. Research Letter (2)
  5. Review (2)
  6. Guidelines (1)
Groups
  1. Breast Medicine Service (175)
  2. Department of Medicine (175)
  3. Solid Tumor Oncology Division (175)
  4. Weinberg Fellows (175)
  5. GSK Faculty (152)
  6. Human Oncology and Pathogenesis Program (124)

More Groups

People
  1. Sarat Chandarlapaty (75)
  2. Jorge Reis-Filho (66)
  3. Michael Berger (45)
  4. Bob Li (41)
  5. David Solit (37)
  6. Dara Ross (32)

More People

Years
  1. 2025 (9)
  2. 2024 (24)
  3. 2023 (11)
  4. 2022 (25)
  5. 2021 (15)
  6. 2020 (38)

More Years

Publications
  1. Journal of Clinical Oncology (35)
  2. Cancer Research (26)
  3. Modern Pathology (9)
  4. Annals of Oncology (8)
  5. Cancer Discovery (7)
  6. International Journal of Radiation Oncology, Biology, Physics (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (41)
  2. American Association for Cancer Research (40)
  3. Nature Publishing Group (28)
  4. Elsevier Inc. (12)
  5. Cell Press (11)
  6. Nature Research (11)

More Publishers

Results (175)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real world outcomes of sequential ADC therapy in metastatic breast cancer: Patients treated with sacituzumab govitecan and trastuzumab deruxtecan
    Meeting Abstract

    Mai, N.; Klar, M.; Ferraro, E.; Bromberg, M.; Chen, Y.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Walsh, E. M.; Drago, J. Z.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Personalized circulating tumor DNA for minimal residual disease and dynamic assessment in patients undergoing neoadjuvant chemotherapy for breast cancer: Preliminary analysis from MSK-LINC
    Meeting Abstract

    Kim, H. K.; An, J. A. R.; Smith, C. G.; Kim, J.; Cabel, L.; Moiso, E.; Ferraro, E.; Safonov, A.; Nelson, K.; Szuhany, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Overall survival analysis of first line CDK4/6 inhibitors in a large real-world cohort of patients with hormone receptor-positive (HR+)/HER2-negative metastatic breast cancer
    Meeting Abstract

    Ferraro, E.; Moiso, E.; Safonov, A.; Cabel, L.; Loudon, L.; Dang, C. T.; Shen, S.; Jhaveri, K. L.; Robson, M. E.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Immune checkpoint inhibition for the treatment of metastatic breast cancer with high tumor mutational burden: Real world clinical and genomic correlates of response
    Meeting Abstract

    Mai, N.; Safonov, A.; Marra, A.; Chen, Y.; Chandarlapaty, S.; Razavi, P.; Plitas, G.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Predicting CDK4/6 inhibitors outcomes in pts with HR+/HER2-metastatic breast cancer: A machine learning approach
    Meeting Abstract

    Moiso, E.; Ferraro, E.; Cabel, L.; Safonov, A.; Ahmed, M.; An, J. A. R.; Jhaveri, K. L.; Norton, L.; Robson, M. E.; Modi, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Genomic biomarkers of CNS-specific outcomes in patients with breast cancer brain metastases
    Meeting Abstract

    Khatri, I. S.; Eichholz, J.; Boe, L. A.; Safonov, A.; Smith, D. R.; Ferraro, E.; Shen, J.; Imber, B. S.; Yu, Y.; Yamada, Y.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Sequential use of PI3K/AKT/mTOR pathway inhibitors alpelisib and everolimus in patients with hormone receptor-positive (HR+) metastatic breast cancer
    Meeting Abstract

    Shen, S.; Safonov, A.; Bromberg, M.; Chen, Y.; Ahmed, M.; Razavi, P.; Jhaveri, K. L.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer
    Journal Article

    Liu, S. Y.; Erazo, T.; Jee, J.; Arfe, A.; Gupta, A.; Pike, L. R. G.; Santini, F. C.; Daly, B.; Schoenfeld, A.; Eichholz, J.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • RB1 genetic alterations in estrogen receptor–positive breast carcinomas: Correlation with neuroendocrine differentiation
    Journal Article

    Schwartz, C. J.; Marra, A.; Selenica, P.; Gazzo, A.; Tan, K.; Ross, D.; Razavi, P.; Chandarlapaty, S.; Weigelt, B.; Reis-Filho, J. S.; more...
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • Impact of cyclin dependent kinase 4/6 inhibitors on breast cancer brain metastasis outcomes
    Journal Article

    Chew, S. M.; Ferraro, E.; Safonov, A.; Chen, Y.; Kelly, D.; Razavi, P.; Robson, M.; Seidman, A. D.
    European Journal of Cancer (2024)

    Fulltext@MSK | Save